These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12433437)

  • 1. Development and in vitro characterisation of a benznidazole liposomal formulation.
    Morilla MJ; Benavidez P; Lopez MO; Bakas L; Romero EL
    Int J Pharm; 2002 Dec; 249(1-2):89-99. PubMed ID: 12433437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?
    Morilla MJ; Prieto MJ; Romero EL
    Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):213-9. PubMed ID: 16021311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough.
    Morilla MJ; Montanari JA; Prieto MJ; Lopez MO; Petray PB; Romero EL
    Int J Pharm; 2004 Jul; 278(2):311-8. PubMed ID: 15196636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment.
    Justo OR; Moraes AM
    J Pharm Pharmacol; 2005 Jan; 57(1):23-30. PubMed ID: 15638989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal benznidazole: a high-performance liquid chromatographic determination for biodistribution studies.
    Morilla MJ; Benavidez PE; Lopez MO; Romero EL
    J Chromatogr Sci; 2003 Sep; 41(8):405-9. PubMed ID: 14558932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation.
    Van Haute D; Jiang W; Mudalige T
    Int J Pharm; 2019 Oct; 569():118603. PubMed ID: 31401296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
    Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
    Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined strategies for liposome characterization during in vitro digestion.
    Hermida LG; Sabés-Xamaní M; Barnadas-Rodríguez R
    J Liposome Res; 2009; 19(3):207-19. PubMed ID: 19548842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease.
    Palmeiro-Roldán R; Fonseca-Berzal C; Gómez-Barrio A; Arán VJ; Escario JA; Torrado-Durán S; Torrado-Santiago S
    Int J Pharm; 2014 Sep; 472(1-2):110-7. PubMed ID: 24928135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood.
    Ishida T; Okada Y; Kobayashi T; Kiwada H
    Int J Pharm; 2006 Feb; 309(1-2):94-100. PubMed ID: 16364578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel liposomal gefitinib (L-GEF) formulations.
    Zhou X; Yung B; Huang Y; Li H; Hu X; Xiang G; Lee RJ
    Anticancer Res; 2012 Jul; 32(7):2919-23. PubMed ID: 22753756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof.
    Levacheva I; Samsonova O; Tazina E; Beck-Broichsitter M; Levachev S; Strehlow B; Baryshnikova M; Oborotova N; Baryshnikov A; Bakowsky U
    Colloids Surf B Biointerfaces; 2014 Sep; 121():248-56. PubMed ID: 25001189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double loading of cyclosporine A in liposomes using cyclodextrin complexes.
    Malaekeh-Nikouei B; Davies N
    PDA J Pharm Sci Technol; 2009; 63(2):139-48. PubMed ID: 19634352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy.
    Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M
    Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B-100-targeted negatively charged nanoliposomes for the treatment of dyslipidemia.
    Sahebkar A; Badiee A; Hatamipour M; Ghayour-Mobarhan M; Jaafari MR
    Colloids Surf B Biointerfaces; 2015 May; 129():71-8. PubMed ID: 25829129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.